Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Algernon Pharmaceuticals Inc. (AGN.V)

HOLD
It produces a drug that has been repurposed for anti-anxiety in Japan. When you look at COVID-19 and its related illnesses, the drug can be used to help with chronic cough and pneumonia. Their chronic cough trial is going into Phase II in Australia. He owns it personally.
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Algernon Pharmaceuticals Inc. (AGN.V) Frequently Asked Questions

What is Algernon Pharmaceuticals Inc. stock symbol?

Algernon Pharmaceuticals Inc. is a OTC stock, trading under the symbol AGN.V (previously AGN-X on Stockchase) on the undefined (undefined). It is usually referred to as or AGN.V

Is Algernon Pharmaceuticals Inc. a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on AGN.V (previously AGN-X on Stockchase) on Stockchase. Read the latest expert commentary for Algernon Pharmaceuticals Inc..

Is Algernon Pharmaceuticals Inc. a good investment or a top pick?

Algernon Pharmaceuticals Inc. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Algernon Pharmaceuticals Inc..

Why is Algernon Pharmaceuticals Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Algernon Pharmaceuticals Inc..

Is Algernon Pharmaceuticals Inc. worth watching?

Algernon Pharmaceuticals Inc. is followed by 12 investors on Stockchase and is a trending stock that is worth watching.